col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


56 Ergebisse       Seite 1

 [1] 
Journal of Applied Pharmacuetical Science: Journal of Applied Pharmaceutical Science
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mrz―10 Evaluating the association between blood types and COVID-19 infection: A retrospective investigation carried out in the Northern Emirates of United Arab Emirates Manjunatha Goud, Manal Mahmoud Sami Mohammed Abdelghani, Laxminarayana Kurady Bairy, Ashika Anu John, enibel Leela Rex Pancras Prabu, Anisha Sridhar, et al. (+3)
2 [GO] 2025―Feb―19 Acceptance and reluctance of COVID-19 vaccination among the general population: a systematic review and meta-analysis of cross-sectional studies Gajalakshmi Thiyagarajan, Vanitha Rani Nagasubramanian, Seetha Lakshmi Ravichandran, Preetha Baskaran, Danya Cendhil Thangam, Rathiesh Kanna Sankaranarayanan, et al. (+5)
3 [GO] 2024―Dez―04 The effect of Citrus reticulata peel extract containing hesperidin on inhibition of SARS-CoV-2 infection based on pseudovirus entry assays Endah Puji Septisetyani, Hayfa Salsabila Harsan, Dennaya Kumara, Pekik Wiji Prasetyaningrum, Komang Alit Paramitasari, Anisa Devi Cahyani, et al. (+5)
4 [GO] 2024―Okt―01 Repurposing of eluxadoline as a SARS-CoV-2 main protease inhibitor: E-Pharmacophore based virtual screening, molecular docking, MM-GBSA calculations, and molecular dynamics simulations studies Magdi A. Mohamed, Alaa F. Alanazi, Waad A. Alanazi, Tilal Elsaman, Malik S. Mohamed, Eyman M. Eltayib
5 [GO] 2024―Sep―24 In silico design of sitagliptin bioisosteres as new inhibitors of Mpro SARS-CoV-2 Abelardo Abad-Giron, Lucero Asmad-Cruz, Angella M. Cordova-Muñoz, Cesar D. Gamarra-Sanchez, Carmen R. Silva-Correa, Víctor E. Villarreal-La Torre
6 [GO] 2024―Aug―22 Flavonoid compound of red fruit papua and its derivatives against sars-cov-2 mpro: An in silico approach Agus Dwi Ananto, Harno Dwi Pranowo, Winarto Haryadi, Niko Prasetyo
7 [GO] 2024―Jul―11 The impact of COVID-19 pandemic on treatment adherence, access to care, and disease control in diabetic patients in Jordan, an online survey Ghaith M. Al-Taani, Suhaib M. Muflih, Rawan Alsharedeh, Reema Karasneh, Sayer I. Al-Azzam
8 [GO] 2024―Apr―09 Computer-aided drug design of novel nirmatrelvir analogs inhibiting main protease of Coronavirus SARS-CoV-2 Kateryna O. Lohachova, Anastasiia S . Sviatenko, Alexander Kyrychenko, Volodymyr V. Ivanov, Tierry Langer, Sergiy M. Kovalenko, Oleg N. Kalugin
9 [GO] 2024―Mrz―05 A comprehensive analysis of public satisfaction: Community pharmacists’ pandemic preparedness in Jordan Derar H. Abdel-Qader, Yara A. Suleiman, Bashar A. Suleiman, Adel H. Suleiman, Salim Hamadi
10 [GO] 2023―Dez―25 Mapping T-cell furin cleavage site epitopes in SARS-CoV-2 spike protein sequences from the Philippines and global variants Maria Crischen Perono, Jewel Pasion, John Sylvester Nas, Francisco III Heralde
11 [GO] 2023―Nov―20 Knowledge, attitude, and perceptions of the public toward the COVID-19 vaccine: A cross-sectional study from India Sameer Dhingra, Arun Chandramohan, Rajasree Udayakumary, Doddolla Lingamaiah, Krishna Murti, Sanjiv Singh, Katia Iskander
12 [GO] 2023―Okt―19 Epidemiologic, clinical, and economic profile of pediatric COVID-19 patients from an Indian context Femida Rashid, Mansi Pawar, Jay Damani, Siddheesh Rajpurohit, Suneel Mundkur, Kanav Khera, Sreedharan Nair
13 [GO] 2023―Okt―05 Traditional Thai herbal medicine for treating COVID-19 Phayong Thepaksorn, Katanchalee Thabsri, Piyachat Evelyn Denbaes, Suwannee Sroisong, Pussadee Srathong, Suriyan Sukati
14 [GO] 2023―Sep―18 Computational design for the development of natural molecules as compelling inhibitors against the target SARS-CoV-2: An in-silico attempt Nagarjuna Palathoti, Kalirajan Rajagopal, Gowramma Byran, Kannan Raman, Edwin Jose, Manikandan Gurunathan
15 [GO] 2023―Sep―13 Identification of potential bioactive compounds from Azadirachta indica (Neem) as inhibitors of SARS-CoV-2 main protease: Molecular docking and molecular dynamics simulation studies Donny Ramadhan, Firdayani Firdayani, Nihayatul Karimah, Elpri Eka Permadi, Sjaikhurrizal El Muttaqien, Agus Supriyono
16 [GO] 2023―Aug―26 The correlation of gene mutation of coagulopathy cascade with elevated D-dimer levels in COVID-19 patients Mohammad Mansour Albalbaki, O’la AL-Fawares, Walid Aburayyan, Nesrin Seder, Ola Mohammed Al-Sanabra, Lamya AL- Tahrawe, Mohammad Nazeeh Shatnawi
17 [GO] 2023―Aug―03 Self-care interventions among the Jordanians during the COVID-19 lockdown: A cross-sectional study of community pharmacists’ observations Isra Dmour, Khawla Dhamen Al-Hamaideh, Safa’a Ali Al- Qudah, Jumanah Dawood Al-Shawabkeh
18 [GO] 2023―Feb―25 The in-silico potential of Andrographis paniculata phytocompounds as antiviral for the treatment of COVID-19: A systematic review Shafa Shavira, Septi Handayani, Fatmaria Fatmaria
19 [GO] 2023―Jan―11 Adverse events associated with COVID-19 treatment and its possible relationship with patient characteristics: A narrative review Omar Yahya Al-Shargi, Samah Mukhlef Alzaid, Bodoor Saud Al-Dosari, Abeer Saad Alzubaidi
20 [GO] 2023―Jan―03 A qualitative exploration of children’s willingness to take the COVID-19 vaccine in Jordan Tareq L. Mukattash, Khalid Ahmed Kheirallah, Hadeel Daradkeh, Anan S. Jarab, Rana K. Abu-Farha, Mohammad B. Nusair, et al. (+2)
21 [GO] 2022―Dez―24 A systematic scoping review of implementation of telepharmacy during COVID-19 Syed Arman Rabbani, Shrestha Sharma, Asiya Mahtab, Faheem Hyder Pottoo, Sathvik B. Sridhar
22 [GO] 2022―Nov―14 Virtual screening campaigns and ADMET evaluation to unlock the potency of flavonoids from Erythrina as 3CLpro SARS-COV-2 inhibitors Vicki Nishinarizki, Ari Hardianto, Shabarni Gaffar, Muchtaridi Muchtaridi, Tati Herlina
23 [GO] 2022―Nov―04 ICT-enabled teaching and learning modalities followed in pharmacy education during COVID-19 in India Sadagoban Gopal Krishnamoorthy, Grace Thomas, Aiswarya Baiju, Shwetha Mariam Philip, Swathi Swaroopa Borra
24 [GO] 2022―Aug―18 The effect of the emerging omicron variant on the willingness to take or continue with COVID-19 vaccination in the Middle East Tareq L. Mukattash, Anan S. Jarab, Rana K. Abu-Farha, Rania Itani, Samar Karout, Razan Z. Mansour, Shorouq Abuhishmah
25 [GO] 2022―Aug―18 Seroprevalence of SARS-CoV-2 antibodies among Jordanian citizens: A cross-sectional study of the demographic and clinical factors that ameliorate serum IgG concentration Walid Abu Rayyan
26 [GO] 2022―Aug―18 Characterization in silico of bioactive compound in tea plant as a potentials inhibitor of SARS-CoV-2 Mpro Mohamad Endy Yulianto, Ari Yuniastuti, Dadan Rohdiana, Vita Paramita, Hermawan Dwi Ariyanto, Rizka Amalia, et al. (+5)
27 [GO] 2022―Aug―18 The shock of the SARS-CoV-2 pandemic on health professionals’ education: A pilot qualitative study in Malaysia Ambigga Krishnapillai, Halyna Lugova, Mainul Haque, Suthahar Ariaratnam, Aznida Firzah Binti Abdul Aziz, Mohammad Nazmul Hasan Maziz, et al. (+12)
28 [GO] 2022―Aug―18 First-generation antipsychotics use and reduced risk of pneumonia-Clinical implications in SARS-CoV2 treatment: A systematic review and meta-analysis of observational studies Abhirami Eby, Elsa Jacob, P. Samuel Gideon George
29 [GO] 2022―Jul―31 The role of influenza vaccination in the COVID-19 infection: Impact on incidence and severity in Iraq Ahmed Mohammed Taqi Al Mosawi, Haitham Mahmood Kadhim, Hussam Majeed Hameed
30 [GO] 2022―Jul―31 Two years of the pandemic: Impact of COVID-19 on tuberculosis management in Nigeria Amarachi Ruth Anigbo, Lokesh Gambhir
31 [GO] 2022―Jul―31 The impact of an educational workshop on counteracting hesitancy toward the COVID-19 vaccine among pharmacy students in Jordan Farah Al-Turk, Amal Akour, Rana Abu Farha
32 [GO] 2022―Jul―31 Computational study of kaurene diterpenoids for antivirals against SARS-CoV-2 Nurlela Nurlela, Fikry Awaluddin, Irmanida Batubara, Setyanto Tri Wahyudi
33 [GO] 2022―Jul―31 Laboratory optimization of the production of guanidium-based inactivated transport media to support SARS-CoV-2 PCR testing in Indonesia Shabarni Gaffar, Hesti Lina Wiraswati, Savira Ekawardhani, Lia Faridah, Nisa Fauziah, Amila Laelalugina, et al. (+8)
34 [GO] 2022―Jul―01 Current regulatory landscape on fast-track pathway for IVDs under COVID-19 heath emergency in India Sella Senthil Marimuthu, Gowthamarajan Kuppusamy, Arun Radhakrishnan, Jithenthiran Saravanan, Indhumathi Thirugnanasambandham
35 [GO] 2022―Jul―01 Challenges and opportunities of clinical pharmacists during COVID-19: A review of the literature Abrar K. Thabit, Jimmy Jose
36 [GO] 2022―Jun―06 The effects of melaleuca cajuput oil (Melaleuca cajuputi) herbal treatment on clinical, laboratory, and radiological improvement and length of hospital stay in COVID-19 patients Desdiani Desdiani, Fadilah Fadilah, Auditya Purwandini Sutarto
37 [GO] 2022―Mai―06 Impact of COVID-19 pandemic on outpatient depression treatment and NHIF expenditure Zornitsa Mitkova, Maria Dimitrova, Javor Mitkov, Guenka Petrova
38 [GO] 2022―Mai―06 Investigating intention to receive the COVID-19 vaccine and willingness to pay among the general public in Pakistan Ali Hassan Gillani, Wenjing Ji, Sumaira Omer, Sadia Bashir, Hafsa Arshad, Jamshaid Akbar, et al. (+3)
39 [GO] 2022―Mai―06 In silico prediction of interactions and molecular dynamics simulation analysis of Mpro of Severe Acute Respiratory Syndrome caused by novel coronavirus 2 with the FDA-approved nonprotein antiviral drugs Subramaniam Sivakumar, Sugumar Mohanasundaram, Narasimhan Rangarajan, Venkatesan Sampath, Maderi Velayutham Dass Prakash
40 [GO] 2022―Apr―05 Variations from SARS-CoV-2 to Omicron: A new threat knocking at World’s door Acharya Balkrishna, Akansha Rohela, Ashwani Kumar, AcVedpriya Arya, Nazam Khan
41 [GO] 2022―Feb―07 Immunomodulatory potential of bioactive compounds of betel leaf extract targeting COVID-19 immunological human host proteins: An in silico study Fatimawali Fatimawali, Kalalo Marko Jeremia, Simanjuntak Siboantua Broolin, Hebber Tri Andira, Kepel Billy Johnson, Tallei Trina Ekawati
42 [GO] 2022―Feb―07 A systematic review on the clinical studies of Remdesivir for COVID-19 in selected Asian countries Querequincia Joseph Mari Baguilod, Faller Erwin Martinez
43 [GO] 2022―Feb―07 Biomarkers for the Recognition of SARS-CoV2-Virus and in the Prediction of COVID-19 Infection Severity Mohd Yusof Yasmin Anum, Haque Mainul
44 [GO] 2022―Jan―05 Happy hypoxemia: A perplexing clinical entity in coronavirus disease 2019 Nair Chithira V., Sathyapalan Dipu T., Moni Merlin, Suresh Akshaya, Roshni Pushpa Raghavan
45 [GO] 2022―Jan―05 Utilization of physical and chemical microbial load reduction agents for SARS-CoV-2: Toxicity and development of drug resistance implications Najib Sani Yahaya, Ayipo Yusuf Oloruntoyin, Shaaban Abubakar, Mordi Mohd Nizam, Abubakar Abdullahi Rabiu, Rowaiye Adekunle Babajide, et al. (+5)
46 [GO] 2021―Dez―06 Key issues surrounding the management of non-communicable diseases including the management of diabetes post COVID-19 among developing countries with a specific focus on Bangladesh Farhana Akter, Mainul Haque, Francis Kalemeera, Amanj Kurdi, Brian Godman
47 [GO] 2021―Nov―01 Unravelling the potentialities of tocilizumab for the development of a potential immunotherapeutic regimen against COVID-19-A narrative review Manish Dhawan, Kuldeep Dhama, Manisha Parmar, Alisha Sharma, Steffy Angural
48 [GO] 2021―Okt―04 Potential ways to address antimicrobial resistance across India and wider exacerbated by COVID-19 Mainul Haque
49 [GO] 2021―Okt―04 Formulation rationale for the development of SARS-COV-2 immunochromatography rapid test kits in India Prince Manta,, Raveen Chauhan,, Himanshu Gandhi,, et al. (+3)
50 [GO] 2021―Aug―08 Review of four major biomolecular target sites for COVID-19 and possible inhibitors as treatment interventions Vigbedor Bright, Tettey Clement Okraku, Essuman Edward Ken, Kyere Isaac, Aniagyei Albert, Kortei Nii Korley, et al. (+2)
51 [GO] 2021―Aug―08 Adverse events reported from the COVID-19 vaccines: A descriptive study based on the WHO database (VigiBase®) Dutta Siddhartha, Kaur Rimple Jeet, Bhardwaj Pankaj, Sharma Praveen, Ambwani Sneha, Islam Salequl, et al. (+7)
52 [GO] 2021―Apr―07 Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19 Dhawan Manish, Parmar Manisha, Sharun Khan, Tiwari Ruchi, Bilal Muhammad, Dhama Kuldeep
53 [GO] 2021―Mrz―09 Immunoinformatics approach in designing SARS-CoV-2 vaccine from experimentally determined SARS-CoV T-cell epitopes Herrera Leana Rich De Mesa
54 [GO] 2021―Feb―07 Exploring public health benefits of Dolichos lablab as a dietary supplement during the COVID-19 outbreak: A computational study Purwanti Elly, Hermanto Feri Eko, Souhaly Jantje Wiliem, Prihanta Wahyu, Permana Tutut Indria
55 [GO] 2020―Dez―07 Screening of Plectranthus amboinicus against COVID-19 - in silico approach Maste Meenaxi M., Saxena Akash
56 [GO] 2020―Mai―09 Repurposing antivirals as potential treatments for SARS-CoV-2: From SARS to COVID-19
 [1] 

56 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec